Alto Neuroscience
ANRO • NYSE
Alto Neuroscience is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Amit Etkin, with a market cap of $654.9M.
CEOAmit Etkin
Next Earnings
Upcoming earnings announcement for Alto Neuroscience
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.51
Earnings History
Past 8 earnings reports for Alto Neuroscience
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q4 2025 | -$0.45Est: -$0.53 | +15.1% | - | — |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.52Est: -$0.65 | +20.0% | - | — | 10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.65Est: -$0.57 | -14.0% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.56 | — | - | — | 10-Q |
| Mar 20, 2025 | Q4 2024 | -$0.56 | — | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.62Est: -$0.64 | +3.1% | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.60Est: -$0.63 | +4.8% | - | — | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.76Est: -$0.46 | -65.2% | - | — | 10-Q |